NewSpring Healthcare Recapitalizes Verisma
December 22, 2021
NewSpring Healthcare led a GP-led secondary recapitalization of Verisma on December 22, 2021, providing liquidity to existing investors (including Blue Heron) and admitting new investors via a continuation vehicle. The transaction injects growth capital to accelerate Verisma's healthcare disclosure management technology and platform while Verisma's management team and board remain largely in place.
- Buyers
- NewSpring Healthcare
- Targets
- Verisma
- Sellers
- NewSpring (existing investor), Blue Heron, Other legacy investors and limited partners
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Verisma Acquires Olah Healthcare Technology
November 20, 2024
Software
Verisma, a provider of health data management solutions, has acquired Olah Healthcare Technology to integrate Olah’s Enterprise Archiving Solution (EAS) into Verisma’s platform. The acquisition is intended to enhance Verisma’s archiving and interoperability capabilities, improving regulatory compliance and data accessibility for hospitals and health systems.
-
Verisma Merges with ScanSTAT, Backed by NewSpring Healthcare
April 13, 2023
Healthcare Services
Verisma and ScanSTAT have merged under the Verisma brand to create a market-leading Release of Information (ROI) and health information management (HIM) provider. NewSpring Healthcare, an existing investor in Verisma, provided funding to facilitate the transaction; ScanSTAT CEO Matt Rohs will join Verisma as Chief of Staff and a board member.
-
NewSpring, Archimedes Health and Heritage Group Invest in Panorama Eye Care
October 14, 2021
Healthcare Services
NewSpring Healthcare, alongside co-investors Archimedes Health Investors and Heritage Group, invested in Panorama Eye Care, a Colorado-based management services organization for regional ophthalmology clinics. The capital is intended to support Panorama’s growth and expansion of clinical and management capabilities across the Mountain West and into additional states.
-
The Vistria Group Recapitalizes Medalogix; Muse Healthcare Consolidates Under Medalogix
May 19, 2021
Healthcare Services
The Vistria Group led a recapitalization and growth investment in Medalogix and Muse Healthcare, consolidating the two data-science and machine-learning businesses under the Medalogix brand to expand clinical decision‑support capabilities for home health, palliative and hospice providers. Minority equity investors in the transaction include LHC Group, Amedisys Home Health and Hospice, and Encompass Health, which will help accelerate adoption across a large nationwide provider footprint.
-
WindRose Health Investors Recapitalizes Veristat Group Inc.
April 7, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.
-
NewSpring Mezzanine Invests in Veritas Medical Solutions
October 15, 2020
Manufacturing
NewSpring Mezzanine, the mezzanine strategy of NewSpring, has made a growth-stage investment in Veritas Medical Solutions, a Harleysville, Pennsylvania-headquartered designer and manufacturer of pre-engineered radiation-shielded treatment facilities. The capital will support Veritas’ product development and expansion to capture growing demand from radiotherapy centers, medical imaging providers and industrial inspection customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.